Suppression of PI3K/Akt/mTOR Signaling Pathway and Antioxidant System and Reversal of Cancer Cells Resistance to Cisplatin under the Effect of Curcumin

被引:0
|
作者
E. V. Kalinina
A. A. Sh. Hasan
V. V. Tatarskiy
Yu. L. Volodina
А. S. Petrova
M. D. Novichkova
D. D. Zhdanov
N. K. Nurmuradov
N. N. Chernov
A. A. Shtil
机构
[1] Peoples’ Friendship University of Russia (RUDN University),T. T. Berezov Department of Biochemistry
[2] Ministry of Health of the Russian Federation,Laboratory of Tumor Cell Death, N. N. Blokhin National Medical Research Center of Oncology
来源
Bulletin of Experimental Biology and Medicine | 2022年 / 173卷
关键词
tumor cells drug resistance; gene expression; PI3K/AkT/mTOR signaling pathway; cisplatin;
D O I
暂无
中图分类号
学科分类号
摘要
The effect of curcumin on the resistance of SKOV-3 human ovarian adenocarcinoma cells to cisplatin was studied. It was found that curcumin induced “reversal” of cancer cells resistance, which was associated with suppression of the expression of genes encoding the key antioxidant enzymes (SOD1, SOD2, CAT, GPX1, and HO-1) and transcription factor Nrf2 and a decrease in the expression of genes encoding kinases of the PI3K/Akt/mTOR signaling pathway. The obtained results confirm the role of redox-dependent regulation in the “reversal” of cancer cells resistance to cisplatin.
引用
收藏
页码:371 / 375
页数:4
相关论文
共 50 条
  • [21] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    HaiXia Li
    JianFang Zeng
    Keng Shen
    Archives of Gynecology and Obstetrics, 2014, 290 : 1067 - 1078
  • [22] A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway
    Li, Baoyu
    Yang, Jingbo
    Lu, Zenghong
    Liu, Bin
    Liu, Fangzhou
    JOURNAL OF BUON, 2019, 24 (02): : 739 - 745
  • [23] Stability Analysis of the PI3K–Akt–mTOR Signaling Pathway
    Sapega T.S.
    Guria G.T.
    Biophysics, 2020, 65 (2) : 259 - 267
  • [24] PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis
    Chen, Qiao Yi
    Costa, Max
    MOLECULAR PHARMACOLOGY, 2018, 94 (01) : 784 - 792
  • [25] AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
    Bhatt, Aadra P.
    Damania, Blossom
    FRONTIERS IN IMMUNOLOGY, 2013, 3
  • [26] Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma
    Dimitrova, V.
    Arcaro, A.
    CURRENT MOLECULAR MEDICINE, 2015, 15 (01) : 82 - 93
  • [27] Effect of glucocorticoids on SCN injury and the PI3K/AKT/mTOR signaling pathway
    Yao, Zhipeng
    Liu, Wenge
    Zhou, Linquan
    Song, Chenyang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (05): : 3679 - 3685
  • [28] Targeting PI3K/AKT/mTOR signaling to overcome drug resistance in cancer
    Tufail, Muhammad
    Wan, Wen-Dong
    Jiang, Canhua
    Li, Ning
    CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 396
  • [29] Ursolic acid-induced autophagy reverses cisplatin resistance in gastric cancer via the PI3K/AKT/mTOR signaling pathway
    Lee, Lien-Chun
    Soh, Tzu-Hsuan
    Hsu, Hsue-Yin
    CANCER SCIENCE, 2018, 109 : 560 - 560
  • [30] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080